We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke)

This study is enrolling participants by invitation only.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01942031
First Posted: September 13, 2013
Last Update Posted: August 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Mia von Euler, Karolinska Institutet
April 15, 2013
September 13, 2013
August 18, 2017
October 2013
December 2015   (Final data collection date for primary outcome measure)
percentage of identified patients with stroke/TIA in primary care and analysis of dispensed prescriptions in each group [ Time Frame: Outcome meassures will be followed during two years ]
percentage of patients identified with hospital discharge diagnosis of stroke/TIA in primary care diagnosis register. Analysis of changes in outcome before intervention and after. the intervention will take place during one year and collection of data before start of intervention and one year after ended intervention will be performed
Same as current
Complete list of historical versions of study NCT01942031 on ClinicalTrials.gov Archive Site
dispensed prescriptions of secondary preventives drugs in patients with stroke/TIA [ Time Frame: baseline 2010 and 2012, followed for one year after intervention ]
dispensed prescriptions of recommended secondary preventive drugs in patients detected and not detected at each primary care center
Same as current
Not Provided
Not Provided
 
Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke)
An Interventional Study of How Collegial Feed Back to Primary Care Physicians on Detection of Diagnosis and Dispensation of Prescribed Secondary Preventive Drugs Affect Stroke Prevention.
Stroke is a devastating disease. The acute mortality in Sweden is 20 % and 25 % of all patients relapse. Secondary prevention is proven efficient but observational studies have shown that a number of patients are lost to follow up and do not receive recommended prevention. The aim of the study is to 1) describe, by analyzing register data, the detection rate of patients with hospital diagnosis of stroke, TIA, and atrial fibrillation in the primary care center where they are listed. The analysis is done by sex, age, and socioeconomic status. Furthermore, rate of dispensed prescriptions of secondary preventive drugs are analysed for the identified population. 2) in a randomized controlled study evaluate if collegial feed back and targeted information of secondary prevention to the intervention group can improve the detection rate and the medication of the patients listed at the participating primary care centers.

All primary care centers in Stockholm County (approximately 200) are randomised to control or intervention (receiving structured feed back on detection rate of stroke/transient ischemic attacks in comparison to hospital discharge registry data. The randomisation is done group wise based on training areas. A data set is presented by different means; 1) in written reports, directly to the head of each primary care center in the intervention group 2)in oral presentation on training sessions for the physicians in each training ares. Measures of detection rates of diagnosis and dispensed prescriptions of secondary preventive drugs are made before start of the project and after one year. The control group, ie the primary care centers not receiving feed back, are measured in the same way and thus provide a control group. The hypothesis being that with visibility of the problem, it is easier to improve care wich is what all health providers aim to do.

Outcome measures is percentage of patients with stroke (ICD code I60, I 61, I63, I64) and transitory ischemic attacks(G45) who are dispensed prescribed secondary preventive medication and death.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
  • Ischemic Stroke
  • Hemorrhagic Stroke
  • TIA
  • Atrial Fibrillation
Behavioral: structured collegial feed back
Collegial feed back to primary care physicians at randomized primary care centers
  • Experimental: structured collegial feed back
    Structured feed back and information about stroke to the primary care center, to physicians and head of the center
    Intervention: Behavioral: structured collegial feed back
  • No Intervention: Control group
    No structured feed back on stroke prevention. Ordinary educational activities only.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
204
March 2018
December 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Primary care center in Stockholm county

Exclusion Criteria:

  • localisation outside Stockholm County
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Sweden
 
 
NCT01942031
EPN2010/1158-31/2
No
Not Provided
Not Provided
Mia von Euler, Karolinska Institutet
Karolinska Institutet
Not Provided
Principal Investigator: Mia von Euler, MD, PhD Karolinska Institutet
Karolinska Institutet
August 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP